Sex differences in the renin-angiotensin-aldosterone system and its roles in hypertension, cardiovascular, and kidney diseases
Related Experiment Video
Updated: Jul 24, 2025

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
Published on: October 26, 2020
Sarah M Nwia1,2, Ana Paula O Leite3, Xiao Chun Li1,2
1Tulane Hypertension and Renal Center of Excellence, Tulane University School of Medicine, New Orleans, LA, United States.
Insights
This review explores sex differences in hypertension, focusing on the renin-angiotensin system. Understanding these biological distinctions is key to developing tailored treatments for cardiovascular disease and improving patient outcomes.
Area of Science:
- Cardiovascular physiology
- Endocrinology
- Hypertension research
Background:
- Cardiovascular disease (CVD) exhibits significant biological sex differences, impacting prevention and treatment strategies.
- Hypertension (high blood pressure) is a primary risk factor for CVD, stroke, and renal failure, affecting nearly half of American adults.
- While women have lower hypertension rates during reproductive years, this protection diminishes post-menopause, and treatment-resistant cases highlight unclear underlying mechanisms.
Purpose of the Study:
- To review recent advances in understanding sex-specific physiological mechanisms influencing the renin-angiotensin system and blood pressure control.
- To discuss the role of genetic and hormonal differences in hypertension development.
- To examine sex disparities in hypertension management, treatment efficacy, and patient outcomes.
Main Methods:
- Literature review of recent research on sex differences in cardiovascular physiology.
- Analysis of studies investigating the renin-angiotensin system in relation to sex hormones and blood pressure.
- Synthesis of epidemiological data and clinical trial findings on hypertension in men and women.
Main Results:
- Biological sex significantly influences cardiovascular disease pathology, including hypertension.
- The renin-angiotensin system's function and its role in blood pressure regulation show distinct sex-based variations.
- Menopause is a critical transition where women's hypertension risk approaches that of men.
Conclusions:
- Tailoring hypertension prevention and treatment based on biological sex is crucial for improving patient outcomes.
- Further research into sex-specific genetic and hormonal mechanisms is needed to address treatment-resistant hypertension.
- Understanding sex differences in the renin-angiotensin system can lead to more effective, personalized therapeutic strategies.
Abstract:
Cardiovascular disease is a pathology that exhibits well-researched biological sex differences, making it possible for physicians to tailor preventative and therapeutic approaches for various diseases. Hypertension, which is defined as blood pressure greater than 130/80 mmHg, is the primary risk factor for developing coronary artery disease, stroke, and renal failure. Approximately 48% of American men and 43% of American women suffer from hypertension. Epidemiological data suggests that during reproductive years, women have much lower rates of hypertension than men. However, this protective effect disappears after the onset of menopause. Treatment-resistant hypertension affects approximately 10.3 million US adults and is unable to be controlled even after implementing ≥3 antihypertensives with complementary mechanisms. This indicates that other mechanisms responsible for modulating blood pressure are still unclear. Understanding the differences in genetic and hormonal mechanisms that lead to hypertension would allow for sex-specific treatment and an opportunity to improve patient outcomes. Therefore, this invited review will review and discuss recent advances in studying the sex-specific physiological mechanisms that affect the renin-angiotensin system and contribute to blood pressure control. It will also discuss research on sex differences in hypertension management, treatment, and outcomes.
Related Concept Videos
Hormonal Regulation
Hypertension II: Pathophysiology
Antihypertensive Drugs: Direct Renin Inhibitors
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Hormonal Regulation of Blood Pressure
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Hypertension and Regulation of Blood Pressure

